The Diagnostic and Prognostic Significance of Inflammatory and Oxidative Stress Markers in Gastrointestinal Pathologies
DOI:
https://doi.org/10.36320/ajb/v18.i2.23776Keywords:
Gastrointestinal diseases, , Oxidative Stress, 8-OHdG, MDA, IL-6Abstract
Although gastrointestinal disorders (GI) present with a diverse array of clinical symptoms, they are fundamentally linked by an underlying biological crosstalk between oxidative stress and chronic inflammation, making it exceptionally difficult to predict disease trajectory or tailor effective treatments. The study aimed to identify and validate a panel of serum- or tissue-based biomarkers that specifically correlate with the severity of inflammation and oxidative stress in patients with different GI diagnoses. This case-control study, conducted from September to December 2025, investigated inflammatory and oxidative stress biomarkers in 128 participants (88 GI patients and 40 healthy controls) at the Hospital of Digestive Diseases in Al-Najaf Al-Ashraf, Iraq. All participants underwent upper gastrointestinal endoscopy, with demographic and clinical data systematically collected. The determination of serum interleukin-6 (IL-6), 8-hydroxy-2′-deoxyguanosine (8-OHdG), and malondialdehyde (MDA) via ELISA, alongside comprehensive biochemical profiling and Helicobacter pylori assessment. Results indicated that GI patients showed significantly higher glucose, TG, NLR, IL-6, MDA, and 8-OHdG levels and decreased hemoglobin and HDL compared to controls (p < 0.05). Specific GI disease subgroups, notably Crohn's disease and ulcerative colitis, demonstrated pronounced elevations in inflammatory and oxidative stress markers. Linear regression highlighted significant associations of 8-OHdG with various clinical and biochemical parameters. Furthermore, multinomial logistic regression identified IL-6 as a significant predictor for Crohn's disease (odds ratio [OR] = 1.34, p = 0.046), while IL-6 (OR = 1.37, p = 0.023), 8-OHdG (OR = 1.01, p = 0.024), and Nes-1 (OR = 0.61, p = 0.007) were predictive for ulcerative colitis. ROC analysis revealed excellent diagnostic performance for IL-6 (AUC = 0.96) and MDA (AUC = 0.89) in distinguishing GI patients from healthy controls. These findings emphasise the vital function of inflammatory and oxidative stress pathways in GI pathologies and suggest these biomarkers hold promise for diagnostic and prognostic applications.
Downloads
References
1. Chen, Q., Wang, X., Peng, J., Huang, S., Luo, R., Li, S., ... & Tang, X. (2025). The burden of digestive diseases in Asian countries and territories from 1990 to 2019: an analysis for the Global Burden of Disease 2019 study. npj Gut and Liver, 2(1), 6.
2. Muro, P., Zhang, L., Li, S., Zhao, Z., Jin, T., & Mao, F. (2024). The emerging role of oxidative stress in inflammatory bowel disease. Frontiers in Endocrinology, 15, 1390351.
3. Mostafavi Abdolmaleky, H., & Zhou, J. R. (2024). Gut microbiota dysbiosis, oxidative stress, inflammation, and epigenetic alterations in metabolic diseases. Antioxidants, 13(8), 985.
4. Smirnova, O., Sinyakov, A., & Kasparov, E. (2025). Cytokine Regulation and Oxidative Stress in Helicobacter Pylori-Associated Gastric Adenocarcinoma at Different Stages: Insights from a Cross-Sectional Study. International Journal of Molecular Sciences, 26(15), 7609.
5. Sahoo, D. K., Heilmann, R. M., Paital, B., Patel, A., Yadav, V. K., Wong, D., & Jergens, A. E. (2023). Oxidative stress, hormones, and effects of natural antioxidants on intestinal inflammation in inflammatory bowel disease. Frontiers in Endocrinology, 14, 1217165.
6. Shin, S., Chen, S., Xie, K., Duhun, S. A., & Ortiz-Cerda, T. (2025). Evaluating the anti-inflammatory and antioxidant efficacy of complementary and alternative medicines (CAM) used for management of inflammatory bowel disease: a comprehensive review. Redox Report, 30(1), 2471737.
7. Nilsson, S., & Ohlsson, B. (2021). Prevalence of gastrointestinal symptoms and irritable bowel syndrome in a Swedish population. Scandinavian Journal of Gastroenterology, 56(1), 44-51.
8. Kilpatrick, L. A., Gupta, A., Tillisch, K., Labus, J. S., Naliboff, B. D., Mayer, E. A., & Chang, L. (2024). Neural correlates of perceived and relative resilience in male and female patients with irritable bowel syndrome. Neurogastroenterology & Motility, 36(2), e14710.
9. Beh, K., Chuah, K., Rappek, N., & Mahadeva, S. (2021). The association of body mass index with functional dyspepsia is independent of psychological morbidity: A cross-sectional study. PLoS ONE, 16.
10. Guo, J., Du, F., Duan, C., Chen, C., Yang, J., Yang, X., ... & Hou, X. (2024). Passive smoking is associated with the risk of functional bowel disorders among college freshmen. Healthcare, 12(23), 2477.
11. Merianos, A., & Mahabee-Gittens, M. (2023). Tobacco Smoke Exposure and Gastrointestinal Problems Among US Children. Clinical Pediatrics, 62, 1229–1236.
12. Majid, Z., & Sharba, I. R. (2025). Low serum vitamin D levels as a risk factor for peptic ulcer development in Iraqi patients. Pharmakeftiki, 37(2S).
13. Assumpção, P. P., Genta, R. M., Camargo, M. C., Silva, J., Amieva, M. R., & Rugge, M. (2024). The Landscape of Helicobacter pylori-related Gastric Carcinogenesis. Journal of Gastrointestinal & Liver Diseases, 33(4).
14. Aniwan, S., Santiago, P., Loftus Jr, E. V., & Park, S. H. (2022). The epidemiology of inflammatory bowel disease in Asia and Asian immigrants to Western countries. United European Gastroenterology Journal, 10(10), 1063-1076.
15. Alshekhani, A. S., Al-Qazaz, H. K., & Al-Salihi, A. R. (2020). Epidemiological profile of inflammatory bowel disease in the Kurdistan region of Iraq. Journal of Crohn's and Colitis, 14(1), 123-130.
16. Hassan, A. J. (2025). Demographic and Clinical Profile of Patients Undergoing Colonoscopy in the Teaching Hospital for Gastroenterology and Hepatology in Sulaymaniyah City, Kurdistan/Iraq. UHD Journal of Science and Technology, 9(2), 129-135.
17. Butkowski, E. G., & Jelinek, H. F. (2017). Hyperglycaemia, oxidative stress and inflammatory markers. Redox Report, 22(1), 1-8.
18. Banerjee, R., Pal, P., Hilmi, I., Ghoshal, U., Desai, D., Rahman, M., and et al. (2022). Emerging inflammatory bowel disease demographics. Journal of Gastroenterology and Hepatology, 37, 1004–1015.
19. Caturano, A., Rocco, M., Tagliaferri, G., Piacevole, A., Nilo, D., Di Lorenzo, G., et al. (2025). Oxidative Stress and Cardiovascular Complications in Type 2 Diabetes. Antioxidants, 14.
20. González, P., Lozano, P., Ros, G., & Solano, F. (2023). Hyperglycemia and Oxidative Stress. International Journal of Molecular Sciences, 24.
21. Tan, S., Yang, X., Mu, X., Liu, S., Wang, Y., Li, Y., ... & Xu, C. (2025). The predictive role of inflammatory markers in IBD. Frontiers in Immunology, 16, 1623899.
22. Cappellini, M. D., et al. (2017). Iron deficiency across chronic inflammatory conditions. American Journal of Hematology, 92(10), 1068–1078.
23. Tratenšek, A., Grabnar, I., Drobne, D., & Vovk, T. (2025). Oxidative stress-related biomarkers in IBD. Antioxidants, 14(10), 1183.
24. Dai, L., et al. (2019). Serum 8-hydroxydeoxyguanosine. European Journal of Internal Medicine, 68, 60–65.
25. Lugo, R., Gutiérrez-Solis, A. L., Jimeno-Figueroa, R. E., Góngora-Chan, P., Vera-Aviles, M., Williams-Jacquez, D., ... & Avila-Nava, A. (2026). Malondialdehyde as a Predictor of Disease Severity and Cardiovascular Risk in Population with Metabolic Dysfunction-Associated Steatotic Liver Disease. Metabolites, 16(3), 203.
26. Vekić, J., Stromsnes, K., Mazzalai, S., Zeljković, A., Rizzo, M., & Gambini, J. (2023). Oxidative Stress and Cardiovascular Risk. Biomedicines, 11.
27. Gulbay, G., & Kaya, Y. (2023). Effects of lipids on inflammation and DNA damage. Medicine Science.
28. Huang, K., Liang, Y., Wang, K., Wu, J., Luo, H., & Yi, B. (2022). Influence of nesfatin-1 on insulin secretion. Frontiers in Public Health, 10.
29. Mohammed, S. A., Sharba, I. R., & Zahid, J. M. (2026). Nesfatin-1 as a bioindicator of metabolic dysregulation. Periódico Tchê Química, 23(52), 109–125.
30. Zhao, J., Lu, Q., Liu, Y., Shi, Z., Hu, L., Zeng, Z., et al. (2021). Th17 Cells in inflammatory bowel disease. Journal of Immunology Research, 2021.
31. Altanam, S. Y., Darwish, N., & Bakillah, A. (2025). Exploring the interplay of antioxidants and inflammation. Diseases, 13(9), 309.
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Intisar Sharba, Swar Adnan Mohammed, Jinan Mohammed Zahid
This work is licensed under a Creative Commons Attribution 4.0 International License.
which allows users to copy, create extracts, abstracts, and new works from the Article, alter and revise the Article, and make commercial use of the Article (including reuse and/or resale of the Article by commercial entities), provided the user gives appropriate credit (with a link to the formal publication through the relevant DOI), provides a link to the license, indicates if changes were made and the licensor is not represented as endorsing the use made of the work.
